Beck, A T., Steer, R.A., y Brown, G.K. (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
Bentley KH, Gallagher MW, Carl JR, Barlow DH Development and validation of the Overall Depression Severity and Impairment Scale. Psychol Assess. 2014 Sep;26(3):815-830. doi: 10.1037/a0036216. Epub 2014 Apr 7.
Echezarraga A, Calvete E, Las Hayas C Validation of the Spanish Version of the Work and Social Adjustment Scale in a Sample of Individuals With Bipolar Disorder. J Psychosoc Nurs Ment Health Serv. 2019 May 1;57(5):44-51. doi: 10.3928/02793695-20181128-02. Epub 2018 Dec 4.
Estevan, P , del Miguel, C., Prigerson, H., García-García, JA., del Cura, & GEDUPROL. (2019). Adaptación trascultural y validación del cuestionario PG-13 para la detección precoz de duelo prolongado. Psicooncología, 14(1), 163-164. https://doi.org/10.5209/PSIC.55820
García-Alandete, J , Martínez, E. R., & Nohales, P. S. (2013). Estructura factorial y consistencia interna de una versión española del Purpose-In-Life Test. Universitas Psychologica, 12(2), 517-530. https://doi.org/10.11144/Javeriana.UPSY12-2.efci
Gu J, Strauss C, Crane C, Barnhofer T, Karl A, Cavanagh K, Kuyken W Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression. Psychol Assess. 2016 Jul;28(7):791-802. doi: 10.1037/pas0000263. Epub 2016 Apr 14.
Limonero Garcia, J , Lacasta Reverte, M., Garcia Garcia, J., Mate Mendez, J., & Prigerson, H. (2009). Adaptación al castellano del inventario de duelo complicado. Medicina Paliativa, 16(5), 291-297.
Mezzich, J E., Cohen, N. L., & Ruiperez, M. A. (1996). A Quality of Life Index: Brief description and validation. Paper presented at the International Congress of the International Federation for Psychiatric Epidemiology. Santiago de Compostela, Spain.
Mundt JC, Marks IM, Shear MK, Greist JH The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4.
Raes F, Pommier E, Neff KD, Van Gucht D Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8.
Sanz, J , Navarro, M. E., y Vázquez, C. (2003). Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 1. Propiedades psicométricas en estudiantes universitarios. Análisis y Modificación de Conducta, 29, 239-288.
Tedeschi RG, Calhoun LG The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996 Jul;9(3):455-71.
Watson D, Clark LA, Tellegen A Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.
Weiss, T , & Berger, R. (2006). Reliability and validity of a Spanish version of the posttraumatic growth inventory. Research on Social Work Practice, 16(2), 191-199. https://doi.org/10.1177/1049731505281374
Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD): An Open Clinical Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.